Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Enoxaparin Metabolism in Reconstructive Surgery Patients

Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus;   Reconstructive Surgery
Intervention:   Drug: Enoxparin
Sponsor:   University of Utah
Recruiting - verified April 2015

Education Bundle to Decrease Patient Refusal of VTE Prophylaxis

Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolism
Intervention:   Behavioral: Patient-centered education bundle
Sponsors:   Johns Hopkins University;   Patient Centered Outcome Research Institute
Enrolling by invitation - verified April 2015

Improving the Stewardship of Diagnostic Imaging Resources in Alberta Emergency Departments

Conditions:   Brain Injuries;   Pulmonary Embolism
Intervention:   Behavioral: Clinical decision support
Sponsors:   University of Calgary;   Alberta Innovates Health Solutions
Not yet recruiting - verified April 2015

OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study

Condition:   Traumatic Intracranial Haemorrhage
Interventions:   Drug: Enoxaparin;   Other: Placebo
Sponsors:   McMaster University;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified April 2015

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions:   Wounds and Injuries;   Acute Coagulopathy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsors:   National Trauma Research Institute;   National Health and Medical Research Council, Australia
Recruiting - verified April 2015

Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study

Conditions:   Morbid Obesity;   Pulmonary Embolism
Interventions:   Drug: Enoxaparin 40 mg 2 hours before arm;   Drug: Enoxaparin 40 mg 12 hours before arm
Sponsor:   Mansoura University
Recruiting - verified April 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Cancer Venous Thromboembolism (VTE)

Conditions:   Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Cancer
Interventions:   Drug: edoxaban;   Drug: Dalteparin
Sponsor:   Daiichi Sankyo Inc.
Recruiting - verified April 2015

HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial

Condition:   Hip Fractures
Intervention:   Other: Accelerated medical clearance and surgery
Sponsors:   Population Health Research Institute;   McMaster University
Recruiting - verified April 2015

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified April 2015

Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication

Condition:   Venous Thrombosis
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Active, not recruiting - verified April 2015

STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial

Conditions:   Intracerebral Haemorrhage;   Stroke
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Neuroscience Trials Australia
Recruiting - verified September 2014

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Development of Computer-aided Detection and Diagnosis From Imaging Techniques

Condition:   Cancer
Sponsor:   National Institutes of Health Clinical Center (CC)
Recruiting - verified April 2014

Odiparcil For The Prevention Of Venous Thromboembolism

Conditions:   Fibrillation, Atrial;   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Interventions:   Drug: Odiparcil;   Drug: Warfarin;   Drug: Coumadin
Sponsor:   GlaxoSmithKline
Completed - verified April 2015

Get CardioSmart

You're Invited